NCT06394791View on ClinicalTrials.gov

Evaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute Obstruction

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Left-sided Colorectal Cancer Complicating Acute Obstruction

Interventions

DRUG

Tislelizumab + IL-2 Combined with Capox

All Listed Sponsors

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT06394791 - Evaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute Obstruction | Biotech Hunter | Biotech Hunter